Tumour eradication using synchronous thermal ablation and Hsp90 chemotherapy with protein engineered triblock biopolymer-geldanamycin conjugates

References

• Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: A retrospective comparative study. J Gastroenterol 2005;40:1054–60
   PubMed Web of Science ®Google Scholar
• Lu DS, Yu NC, Raman SS, Limanond P, Lassman C, Murray K, et al. Radiofrequency ablation of hepatocellular carcinoma: Treatment success as defined by histologic examination of the explanted liver. Radiology 2005;234:954–60
   PubMed Web of Science ®Google Scholar
• Park W, Chung YH, Kim JA, Jin YJ, Lee D, Shim JH, et al. Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns. Hepatol Res 2013;43:1304–12
   PubMed Web of Science ®Google Scholar
• Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, et al. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: Results and prognostic factors on long-term follow up. J Gastroenterol Hepatol 2010;25:597–604
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang C, Lu Y, Bai W, An L, Qu J, et al. Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2012;19:674–84
   Google Scholar
• Liu Q, Zhai B, Yang W, Yu LX, Dong W, He YQ, et al. Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine. Mol Ther 2009;17:2049–57
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao J, Guo D, Zhong W, Ran L. Evaluation of short-term response of high intensity focused ultrasound ablation for primary hepatic carcinoma: Utility of contrast-enhanced MRI and diffusion-weighted imaging. Eur J Radiol 2011;79:347–52
   Google Scholar
• Cheung TT, Fan ST, Chu FS, Jenkins CR, Chok KS, Tsang SH, et al. Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma. HPB 2013;15:567–73
   PubMed Web of Science ®Google Scholar
• Itoh S, Ikeda Y, Kawanaka H, Okuyama T, Kawasaki K, Eguchi D, et al. Efficacy of surgical microwave therapy in patients with unresectable hepatocellular carcinoma. Ann Surg Oncol 2011;18:3650–56
   Google Scholar
• Liu Y, Zheng Y, Li S, Li B, Zhang Y, Yuan Y. Percutaneous microwave ablation of larger hepatocellular carcinoma. Clin Radiol 2013;68:21–6
   PubMed Web of Science ®Google Scholar
• Veltri A, Guarnieri T, Gazzera C, Busso M, Solitro F, Fora G, et al. Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): Size as the leading prognostic factor for survival. Radiol Med 2012;117:1139–51
   PubMed Web of Science ®Google Scholar
• Yamakado K, Nakatsuka A, Ohmori S, Shiraki K, Nakano T, Ikoma J, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: Treatment response based on tumor size and morphology. J Vasc Interv Radiol 2002;13:1225–32
   PubMed Web of Science ®Google Scholar
• Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: Multivariate meta-analysis and review of contributing factors. Ann Surg 2005;242:158–71
   PubMed Web of Science ®Google Scholar
• Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:1151–6
   PubMed Web of Science ®Google Scholar
• Wiggermann P, Puls R, Vasilj A, Sieron D, Schreyer AG, Jung EM, et al. Thermal ablation of unresectable liver tumors: Factors associated with partial ablation and the impact on long-term survival. Med Sci Monit 2012;18:CR88–92
   Google Scholar
• Schumann C, Rieder C, Bieberstein J, Weihusen A, Zidowitz S, Moltz JH, et al. State of the art in computer-assisted planning, intervention, and assessment of liver-tumor ablation. Crit Rev Biomed Eng 2010;38:31–52
   PubMedGoogle Scholar
• Goldberg SN, Solbiati L. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:609–11
   Google Scholar
• Kuszyk BS, Boitnott JK, Choti MA, Bluemke DA, Sheth S, Magee CA, et al. Local tumor recurrence following hepatic cryoablation: Radiologic-histopathologic correlation in a rabbit model. Radiology 2000;217:477–86
   Google Scholar
• Supic G, Kozomara R, Jovic N, Zeljic K, Magic Z. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas. Oral Oncol 2011;47:702–8
   PubMed Web of Science ®Google Scholar
• Kim YS, Rhim H, Cho OK, Koh BH, Kim Y. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors. Eur J Radiol 2006;59:432–41
   PubMed Web of Science ®Google Scholar
• Berber E, Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: An analysis of 1032 tumors. Ann Surg Oncol 2008;15:2757–64
   PubMed Web of Science ®Google Scholar
• Yoshida S, Kornek M, Ikenaga N, Schmelzle M, Masuzaki R, Csizmadia E, et al. Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma. Hepatology 2013;58:1667–80
   PubMed Web of Science ®Google Scholar
• Burks SR, Ziadloo A, Hancock HA, Chaudhry A, Dean DD, Lewis BK, et al. Investigation of cellular and molecular responses to pulsed focused ultrasound in a mouse model. PLoS One 2011;6:e24730
   PubMed Web of Science ®Google Scholar
• Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets. Semin Cancer Biol 2011;21:35–43
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013;19:1423–37
   PubMed Web of Science ®Google Scholar
• Groeschl RT, Wong RK, Quebbeman EJ, Tsai S, Turaga KK, Pappas SG, et al. Recurrence after microwave ablation of liver malignancies: A single institution experience. HPB 2013;15:365–71
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Kamel IR, Kruskal JB, Reynolds K, Monsky WL, Stuart KE, et al. Radiofrequency ablation of hepatic tumors: Increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgenol 2002;179:93–101
   PubMed Web of Science ®Google Scholar
• Yang W, Ahmed M, Elian M, Hady el-SA, Levchenko TS, Sawant RR, et al. Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model? Radiology 2010;257:685–96
   PubMed Web of Science ®Google Scholar
• Yang W, Ahmed M, Tasawwar B, Levchenko T, Sawant RR, Collins M, et al. Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model. Int J Hyperthermia 2011;27:527–38
   PubMed Web of Science ®Google Scholar
• Kroeze SGC, Van Melick HHE, Nijkamp MW, Kruse FK, Kruijssen LWJ, Van Diest PJ, et al. Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model. BJU Int 2012;110:E281–6
   PubMed Web of Science ®Google Scholar
• Sajjadi AY, Mitra K, Grace M. Expression of heat shock proteins 70 and 47 in tissues following short-pulse laser irradiation: Assessment of thermal damage and healing. Med Eng Phys 2013;35:1406–14
   PubMed Web of Science ®Google Scholar
• Parsell DA, Lindquist S. The function of heat-shock proteins in stress tolerance: Degradation and reactivation of damaged proteins. Annu Rev Genet 1993;27:437–96
   PubMed Web of Science ®Google Scholar
• Yavelsky V, Vais O, Piura B, Wolfson M, Rabinovich A, Fraifeld V. The role of Hsp90 in cell response to hyperthermia. J Therm Biol 2004;29:509–14
   Google Scholar
• Sun Y, Zang Z, Xu X, Zhang Z, Zhong L, Zan W, et al. Differential proteomics identification of Hsp90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry. Int J Mol Sci 2010;11:1423–33
   PubMed Web of Science ®Google Scholar
• Koga F, Kihara K, Neckers L. Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90. Anticancer Res 2009;29:797–807
   PubMed Web of Science ®Google Scholar
• Bohonowych JE, Gopal U, Isaacs JS. Hsp90 as a gatekeeper of tumor angiogenesis: Clinical promise and potential pitfalls. J Oncol 2010;2010:412985
   PubMedGoogle Scholar
• Teng Y, Ngoka L, Mei Y, Lesoon L, Cowell JK. Hsp90 and Hsp70 proteins are essential for stabilization and activation of WASF3 metastasis-promoting protein. J Bio Chem 2012;287:10051–9
   Google Scholar
• Roe SM, Prodromou C, O’Brien R, Ladbury JE, Piper PW, Pearl LH. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J Med Chem 1999;42:260–6
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV, Toretsky J, Neckers L. Geldanamycin selectively destabilizes and conformationally alters mutated p53. Oncogene 1995;11:93393–9
   Google Scholar
• Supko JG, Hickman RL, Grever MR, Malspeis L. Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent. Cancer Chemother Pharmacol 1995;36:305–15
   PubMed Web of Science ®Google Scholar
• Chilkoti A, Dreher MR, Meyer DE. Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. Adv Drug Deliv Rev 2002;54:1093–111
   PubMed Web of Science ®Google Scholar
• Urry DW, Trapane TL, Prasad KU. Phase-structure transitions of the elastin polypentapeptide-water system within the framework of composition-temperature studies. Biopolymers 1985;24:2345–56
   PubMed Web of Science ®Google Scholar
• Furgeson DY, Dreher MR, Chilkoti A. Structural optimization of a ‘smart’ doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors. J Control Release 2006;110:362–9
   PubMed Web of Science ®Google Scholar
• Chen Y, Youn P, Furgeson DY. Thermo-targeted drug delivery of geldanamycin to hyperthermic tumor margins with diblock elastin-based biopolymers. J Control Release 2011;155:175–83
   PubMedGoogle Scholar
• Fujita Y, Mie M, Kobatake E. Construction of nanoscale protein particle using temperature-sensitive elastin-like peptide and polyaspartic acid chain. Biomaterials 2009;30:3450–7
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000;65:271–84
   PubMed Web of Science ®Google Scholar
• Szmacinski H, Lakowicz JR. Optical measurements of pH using fluorescence lifetimes and phase-modulation fluorometry. Ann Chem 1993;65:1668–74
   Google Scholar
• Bae Y, Buresh RA, Williamson TP, Chen THH, Furgeson DY. Intelligent biosynthetic nanobiomaterials for hyperthermic combination chemotherapy and thermal drug targeting of Hsp90 inhibitor geldanamycin. J Control Release 2007;122:16–23
   PubMed Web of Science ®Google Scholar
• Ito A, Saito H, Mitobe K, Minamiya Y, Takahashi N, Maruyama K, et al. Inhibition of heat shock protein 90 sensitizes melanoma cells to thermosensitive ferromagnetic particle-mediated hyperthermia with low Curie temperature. Cancer Sci 2009;100:558–64
   PubMed Web of Science ®Google Scholar
• Larson N, Gormley A, Frazier N, Ghandehari H. Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer–drug conjugates and gold nanorod induced hyperthermia. J Control Release 2013;170:41–50
   PubMed Web of Science ®Google Scholar
• Song CW, Kang MS, Rhee JG, Levitt SH. The effect of hyperthermia on vascular function, pH, and cell survival. Radiology 1980;137:795–803
   PubMed Web of Science ®Google Scholar
• Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res 2000;60:6950–7
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002;43:33–56
   PubMed Web of Science ®Google Scholar
• Huang HW. Influence of blood vessel on the thermal lesion formation during radiofrequency ablation for liver tumors. Med Phys 2013;40:073303
   PubMed Web of Science ®Google Scholar
• Raucher D, Chilkoti A. Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition. Cancer Res 2001;61:7163–70
   PubMed Web of Science ®Google Scholar
• Wang LH, Rothberg KG, Anderson RG. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993;123:1107–17
   PubMed Web of Science ®Google Scholar
• Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. Am J Roentgenol 2003;180:441–54
   Google Scholar
• Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res 2005;127:208–23
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: Biological mechanisms and advances in therapy. Nat Rev Cancer 2014;14:199–208
   PubMed Web of Science ®Google Scholar
• Wright AS, Lee FT, Jr Mahvi DM. Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 2003;10:275–83
   PubMed Web of Science ®Google Scholar
• Dong BW, Zhang J, Liang P, Yu XL, Su L, Yu DJ, et al. Sequential pathological and immunologic analysis of percutaneous microwave coagulation therapy of hepatocellular carcinoma. Int J Hyperthermia 2003;19:119–33
   PubMed Web of Science ®Google Scholar
• Mala T. Cryoablation of liver tumours – A review of mechanisms, techniques and clinical outcome. Minim Invasive Ther Allied Technol 2006;15:9–17
   PubMed Web of Science ®Google Scholar
• de Baere T, Elias D, Dromain C, Din MG, Kuoch V, Ducreux M, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. Am J Roentgenol 2000;175:1619–25
   PubMed Web of Science ®Google Scholar
• Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000;7:593–600
   PubMed Web of Science ®Google Scholar
• Fajardo LF, Egbert B, Marmor J, Hahn GM. Effects of hyperthermia in a malignant tumor. Cancer 1980;45:613–23
   PubMed Web of Science ®Google Scholar
• Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: Outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 2006;17:1117–24
   PubMed Web of Science ®Google Scholar
• Ahmed M, Goldberg SN. Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Int J Hyperthermia 2004;20:781–802
   PubMed Web of Science ®Google Scholar
• Horkan C, Dalal K, Coderre JA, Kiger JL, Dupuy DE, Signoretti S, et al. Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model. Radiology 2005;235:81–8
   PubMed Web of Science ®Google Scholar
• Barnes KD, Shafirstein G, Webber JS, Koonce NA, Harris Z, Griffin RJ. Hyperthermia-enhanced indocyanine green delivery for laser-induced thermal ablation of carcinomas. Int J Hyperthermia 2013;29:474–9
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Girnan GD, Lukyanov AN, Ahmed M, Monsky WL, Gazelle GS, et al. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology 2002;222:797–804
   PubMed Web of Science ®Google Scholar
• Lindner LH, Eichhorn ME, Eibl H, Teichert N, Schmitt-Sody M, Issels RD, et al. Novel temperature-sensitive liposomes with prolonged circulation time. Clin Cancer Res 2004;10:2168–78
   PubMed Web of Science ®Google Scholar
• MacKay JA, Chen M, McDaniel JR, Liu W, Simnick AJ, Chilkoti A. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat Mater 2009;8:993–9
   PubMed Web of Science ®Google Scholar
• McDaniel JR, Macewan SR, Li X, Radford DC, Landon CD, Dewhirst M, et al. Rational design of ‘heat seeking’ drug loaded polypeptide nanoparticles that thermally target solid tumors. Nano Lett 2014;14:2890–5
   PubMed Web of Science ®Google Scholar